| Product NDC: | 25021-101 | 
| Proprietary Name: | Cefazolin | 
| Non Proprietary Name: | cefazolin sodium | 
| Active Ingredient(s): | 1 g/3mL & nbsp; cefazolin sodium | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25021-101 | 
| Labeler Name: | Sagent Pharmaceuticals | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA063207 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20090201 | 
| Package NDC: | 25021-101-10 | 
| Package Description: | 25 VIAL in 1 CARTON (25021-101-10) > 3 mL in 1 VIAL | 
| NDC Code | 25021-101-10 | 
| Proprietary Name | Cefazolin | 
| Package Description | 25 VIAL in 1 CARTON (25021-101-10) > 3 mL in 1 VIAL | 
| Product NDC | 25021-101 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | cefazolin sodium | 
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20090201 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sagent Pharmaceuticals | 
| Substance Name | CEFAZOLIN SODIUM | 
| Strength Number | 1 | 
| Strength Unit | g/3mL | 
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |